PNE Delivered With a VR Headset in Outpatient LBP Patients

April 11, 2023 updated by: David Saul Binder, Spaulding Rehabilitation Hospital

Exploring the Feasibility and Acceptability of Pain Neuroscience Education Delivered With a Virtual Reality Headset to Outpatient Physical Therapy Patients Treated for Low Back Pain: a Pilot Multi-site Implementation Trial

The primary objective of this study is to explore the feasibility and acceptability of the delivery of educational content using a virtual reality headset in the setting of an outpatient physical therapy (PT) course of care for chronic low back pain. We aim to collect both qualitative and quantitative data regarding: 1) specifics of device use in the course of PT care 2) acceptability of both the content and delivery method from the therapist and subject perspective 3) subject attributes to characterize the study population and explore possible associations with content responses and 4) changes in pain knowledge from pre to post intervention. Information learned in this pilot study will assist us in 1) improving the content and delivery method of a chronic pain education program 2) implementing the program across the Spaulding rehabilitation network and 3) designing a more rigorous effectiveness trial.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Study staff physical therapists will identify potential subjects upon completion of a standard physical therapy evaluation on patients referred for low back pain. Spaulding Outpatient sites in Malden, Quincy YMCA and Charlestown will participate.

  • Inclusion criteria: 1) pain lasting > 3 months and 2) > 18 years of age
  • Exclusion criteria: 1) inability to understand and communicate in English 2) inability to provide informed consent Individuals who meet the inclusion/exclusion criteria will receive an information study sheet, the full consent form for reference, and hear a brief explanation of the study from the treating study staff physical therapist. It will be emphasized that study participation is completely voluntary and refusal to participate will in no way impact their care at that clinic site or other MGB facilities either now or in the future.

SUBJECT ENROLLMENT

Once an eligible subject is identified, the evaluating study staff physical therapist will briefly introduce the study and provide the study information sheet and full consent form for review. Interested individuals will be contacted by phone by study staff. Study staff obtaining consent will discuss the details of the study with the individual using the full consent form and study information sheet as a guide and will cover all of the required elements of informed consent, including the purpose of the research, the study procedures, risks and benefits associated with participation, and answer study-related questions. Subjects will be advised that their clinical care will not be affected in any way if they decide to participate or decline participation, and that participation can be discontinued at any time. The principal investigator's and consenting study staff's contact information will be provided on the information sheet and consent form, and other study staff will provide their contact information as appropriate. The study will be explained in detail and the individual will be given the chance to ask any questions. Informed consent will be obtained verbally over the phone due to the minimal study risk, low study burden, and the necessity of limiting in-person contact. Study staff will document verbal consent by electronically signing a copy of the IRB approved telephone information consent document which will be electronically stored in a protected Dropbox file that only study staff will have access to. Paper consent forms will not be stored. A copy will be securely emailed via Outlook to the treating study staff physical therapist. This copy will be printed and provided to the subject in-person by the treating study staff physical therapist at the subject's next scheduled physical therapy visit.

Due to the minimal risk involved, informed consent may be given with less than 12 hours of notice, or they may be given additional time to consider.

STUDY PROCEDURES

Study staff physical therapists will be informed of enrollment. Once enrolled, subjects will complete the Keele STarT back questionnaire and a pain knowledge check. The pain education content will be delivered via the Oculus Go virtual reality (VR) headset at the beginning or end of the subjects scheduled PT appointments. There will be no added costs for content delivery and no additional study visits will be required outside of the regularly scheduled PT visits. Upon completing the pain education series, subjects will complete a feedback survey and a post-pain knowledge check. Study staff physical therapists will complete a survey for each enrolled subject.

Additionally, demographic information will be collected from the Epic electronic health record (EHR) such as: age, gender, educational level, relevant past medical history, results of relevant images, and pertinent physical therapy evaluation and treatment information that is standard of care for this patient population. This information will be used to characterize the study sample and begin to identify important attributes that may have more relevance regarding the response to the content.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • United States
    • Massachusetts
      • Boston, Massachusetts, United States, 02129
        • Spaulding Rehabilitation Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

chronic low back pain patients referred for outpatient physical therapy

Description

Inclusion Criteria:

  • pain lasting > 3 months
  • 18 years of age or older

Exclusion Criteria:

  • inability to understand and communicate in English
  • inability to give informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Pain knowledge and beliefs questionnaire
Time Frame: Through study completion; an average of 4 clinical sessions delivered over 2 to 4 weeks
assesses change in subject's knowledge and beliefs about pain
Through study completion; an average of 4 clinical sessions delivered over 2 to 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Spaulding Rehabilitation Hospital

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: David Binder, MD, Spaulding Rehabilitation Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
February 18, 2021

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
August 31, 2022

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
August 31, 2022

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 22, 2021

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 26, 2021

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 2, 2021

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 12, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 11, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
April 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2021P000203

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on Pain Neuroscience Education delivered via a Virtual Reality Headset

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings